Thought Field Therapy and Cognitive Therapy for Agoraphobia

Thought Field Therapy and Cognitive Therapy for Agoraphobia - a Randomized Controlled Intervention Study Where the Efficacy of Thought Field Therapy is to be Compared to Cognitive Therapy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00932919

Enrollment

Registered

2009-07-07

Start date

2006-10-31

Completion date

2010-11-30

Last updated

2014-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agoraphobia

Keywords

Agoraphobia, Cognitive therapy, Thought field therapy, Psychotherapy research

Brief summary

The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.

Detailed description

Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies. Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment. All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.

Interventions

BEHAVIORALThought field therapy

5 sessions with Thought field therapy

BEHAVIORALCognitive therapy

12 sessions of Cognitive therapy

BEHAVIORALWait list

3 months waiting, then randomized to either thought field therapy or cognitive therapy

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients ages 18 years or older, * Patients with agoraphobia, * Patients with a score on Mobility Inventory Alone of 2.5 or more, * Patients who give a written consent to participate.

Exclusion criteria

* Psychosis (past or present), * Drug abuse or dependency, * Moderate or high score on suicidal behaviour on the M.I.N.I., * Patients who have another illness (other than panic disorder or agoraphobia) and are in need of immediate treatment.

Design outcomes

Primary

Measure	Time frame
Change in agoraphobic situation scores in ADIS.	Immedeately and 12 months after treatment

Secondary

Measure	Time frame
BDI	Immediately and 12 months after treatment
BAI	Immediately and 12 months after treatment
WHOQOL-BREF	Immediately and 12 months after treatment
SF-36	Immediately and 12 months after treatment
Body Sensations Questionnaire	Immediately and 12 months after treatment
Panic scale	Immediately and 12 months after treatment
Interference score in ADIS	Immediately and 12 months after treatment
Mobility Inventory	Immediately and 12 months after treatment
Agoraphobic Cognitions Questionnaire	Immediately and 12 months after treatment
Safety Seeking Behaviours Questionnaire.	Immediately and 12 months after treatment

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 26, 2026